WO1999067019A1 - Combinatorial electrochemical syntheses - Google Patents
Combinatorial electrochemical syntheses Download PDFInfo
- Publication number
- WO1999067019A1 WO1999067019A1 PCT/US1999/014459 US9914459W WO9967019A1 WO 1999067019 A1 WO1999067019 A1 WO 1999067019A1 US 9914459 W US9914459 W US 9914459W WO 9967019 A1 WO9967019 A1 WO 9967019A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- microelectrode
- potential
- electrode
- microelectrodes
- array
- Prior art date
Links
- 238000003786 synthesis reaction Methods 0.000 title claims abstract description 31
- 150000001875 compounds Chemical class 0.000 claims abstract description 19
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 9
- 229910001092 metal group alloy Inorganic materials 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 59
- 238000000034 method Methods 0.000 claims description 53
- 239000011159 matrix material Substances 0.000 claims description 29
- 229910052751 metal Inorganic materials 0.000 claims description 28
- 239000002184 metal Substances 0.000 claims description 28
- 239000000376 reactant Substances 0.000 claims description 27
- 150000002500 ions Chemical class 0.000 claims description 22
- 230000015572 biosynthetic process Effects 0.000 claims description 21
- -1 Mg" Chemical class 0.000 claims description 18
- 230000008859 change Effects 0.000 claims description 16
- 229920000642 polymer Polymers 0.000 claims description 16
- 150000001412 amines Chemical class 0.000 claims description 10
- 229910010272 inorganic material Inorganic materials 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- 150000001413 amino acids Chemical class 0.000 claims description 8
- 229910052799 carbon Inorganic materials 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 239000013626 chemical specie Substances 0.000 claims description 6
- 150000002484 inorganic compounds Chemical class 0.000 claims description 6
- 125000003729 nucleotide group Chemical group 0.000 claims description 6
- 230000003647 oxidation Effects 0.000 claims description 6
- 238000007254 oxidation reaction Methods 0.000 claims description 6
- 230000010287 polarization Effects 0.000 claims description 6
- 229910045601 alloy Inorganic materials 0.000 claims description 5
- 239000000956 alloy Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 150000002739 metals Chemical class 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 5
- 229910052707 ruthenium Inorganic materials 0.000 claims description 5
- 150000001299 aldehydes Chemical class 0.000 claims description 4
- 238000004090 dissolution Methods 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 4
- 229910052762 osmium Inorganic materials 0.000 claims description 4
- 230000009467 reduction Effects 0.000 claims description 4
- 238000007596 consolidation process Methods 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 150000001735 carboxylic acids Chemical class 0.000 claims description 2
- 238000005530 etching Methods 0.000 claims description 2
- 238000005486 sulfidation Methods 0.000 claims description 2
- 229910052723 transition metal Inorganic materials 0.000 claims description 2
- 150000003624 transition metals Chemical class 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 239000000178 monomer Substances 0.000 claims 1
- 108091034117 Oligonucleotide Proteins 0.000 abstract description 12
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract description 12
- 238000003491 array Methods 0.000 abstract description 8
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 7
- 239000000243 solution Substances 0.000 description 28
- 230000008569 process Effects 0.000 description 16
- 241000894007 species Species 0.000 description 16
- 150000001450 anions Chemical class 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 230000008878 coupling Effects 0.000 description 10
- 238000010168 coupling process Methods 0.000 description 10
- 238000005859 coupling reaction Methods 0.000 description 10
- 238000006056 electrooxidation reaction Methods 0.000 description 10
- 229940088598 enzyme Drugs 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 9
- 238000010586 diagram Methods 0.000 description 8
- 150000001768 cations Chemical class 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000000017 hydrogel Substances 0.000 description 6
- 239000010410 layer Substances 0.000 description 6
- 125000006239 protecting group Chemical group 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 150000001408 amides Chemical class 0.000 description 5
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 239000004020 conductor Substances 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 5
- 229910052737 gold Inorganic materials 0.000 description 5
- 239000010931 gold Substances 0.000 description 5
- 150000002736 metal compounds Chemical class 0.000 description 5
- 150000002894 organic compounds Chemical class 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 4
- 102000015636 Oligopeptides Human genes 0.000 description 4
- 108010038807 Oligopeptides Proteins 0.000 description 4
- 108091093037 Peptide nucleic acid Proteins 0.000 description 4
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 4
- 150000001718 carbodiimides Chemical class 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 229910052710 silicon Inorganic materials 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000008364 bulk solution Substances 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 229910017052 cobalt Inorganic materials 0.000 description 3
- 239000010941 cobalt Substances 0.000 description 3
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005868 electrolysis reaction Methods 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 239000012212 insulator Substances 0.000 description 3
- 229910021645 metal ion Inorganic materials 0.000 description 3
- 229910044991 metal oxide Inorganic materials 0.000 description 3
- 150000004706 metal oxides Chemical class 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 229940072107 ascorbate Drugs 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000006482 condensation reaction Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical class Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 2
- 238000003487 electrochemical reaction Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 150000008300 phosphoramidites Chemical class 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000001846 repelling effect Effects 0.000 description 2
- WOCIAKWEIIZHES-UHFFFAOYSA-N ruthenium(iv) oxide Chemical compound O=[Ru]=O WOCIAKWEIIZHES-UHFFFAOYSA-N 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- IZQAUUVBKYXMET-UHFFFAOYSA-N 2-bromoethanamine Chemical compound NCCBr IZQAUUVBKYXMET-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 108700023418 Amidases Proteins 0.000 description 1
- 102000004092 Amidohydrolases Human genes 0.000 description 1
- 108090000531 Amidohydrolases Proteins 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- 108010059724 Micrococcal Nuclease Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 150000007930 O-acyl isoureas Chemical class 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 229910052581 Si3N4 Inorganic materials 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 150000001347 alkyl bromides Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 150000001351 alkyl iodides Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 102000005922 amidase Human genes 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229940075397 calomel Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005518 electrochemistry Effects 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical class [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 150000002463 imidates Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000001465 metallisation Methods 0.000 description 1
- BFXIKLCIZHOAAZ-UHFFFAOYSA-N methyltrimethoxysilane Chemical compound CO[Si](C)(OC)OC BFXIKLCIZHOAAZ-UHFFFAOYSA-N 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 150000004767 nitrides Chemical class 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 229910052702 rhenium Inorganic materials 0.000 description 1
- WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B80/00—Linkers or spacers specially adapted for combinatorial chemistry or libraries, e.g. traceless linkers or safety-catch linkers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00353—Pumps
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00389—Feeding through valves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00612—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports the surface being inorganic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00614—Delimitation of the attachment areas
- B01J2219/00621—Delimitation of the attachment areas by physical means, e.g. trenches, raised areas
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00623—Immobilisation or binding
- B01J2219/00626—Covalent
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00623—Immobilisation or binding
- B01J2219/00628—Ionic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00632—Introduction of reactive groups to the surface
- B01J2219/00637—Introduction of reactive groups to the surface by coating it with another layer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00653—Making arrays on substantially continuous surfaces the compounds being bound to electrodes embedded in or on the solid supports
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00686—Automatic
- B01J2219/00689—Automatic using computers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00709—Type of synthesis
- B01J2219/00713—Electrochemical synthesis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/00745—Inorganic compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/00745—Inorganic compounds
- B01J2219/0075—Metal based compounds
- B01J2219/00752—Alloys
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/01—Charge-transfer complexes
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/18—Libraries containing only inorganic compounds or inorganic materials
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
- C40B60/14—Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries
Definitions
- the present invention is generally related to the combinatorial syntheses of compounds, particularly of biological compounds and metal alloys, on microelectrode arrays.
- the invention relates in particular to the combinatorial syntheses of oligonucleotides, peptides and biologically active compounds on microelectrode arrays under electrochemical control.
- the simultaneous synthesis of massive numbers of different oligonucleotides, peptides, and biologically active compounds has applications in the identification of new drugs, in the mapping of genes, and in testing for interactions between biological molecules.
- Arrays of different genes are applied, for example, in diagnosing various diseases, such as cancer and hereditary diseases, in sequencing the human genome, and identification of drugs capable of blocking bioconjugation reactions.
- the present invention provides a method for parallel syntheses where a specific reaction is induced and controlled at the microelectrode.
- the present invention provides an electronic device and method for the combinatorial synthesis of biopolymers, alloys, and non-stochiometric inorganic compounds.
- the device includes an array of selectively addressable microelecrodes which preferably includes on its surface a conductive matrix, which may be a redox polymer or hydrogel.
- the matrix further comprises functional reactive groups, such as amines, aldehydes, carboxyllic acids, active esters, and the like, useful for the sequential addition of monomeric units to form polymeric compounds.
- the array includes amines in the matrix, to which nucleotides or oligonucleotides may be sequentially added by chemical reaction.
- a potential sufficient to induce a Faradaic reaction is selectively applied to each microelectrode to induce binding of a reactant to one or more of the functional reactive groups in the matrix.
- a complex compound is synthesized on the microelectrode by repeated Faradaic reactions, i.e., by repeated applications of a potential sufficient to induce the desired reactions.
- the method of the invention includes application of a potential to induce a Faradaic reaction and selectively deposit metals in layers onto a microelectrode.
- a portion of one or more of the metal layers is etched or dissolved via subsequent Faradaic reaction at the microelectrode. Heating, oxadation, sulfadation, or consolidation of two or more layers causes formation of an alloy or non-stochiometric inorganic compound.
- Figure l is a diagram showing the arrangement of the electrode or array surface bearing the reactive groups as a monolayer or in a polymeric matrix.
- the electrode surface is schematically drawn as a flat surface but the surface roughness (geometric area/actual area) may vary between 1 and 1000.
- Figure 2 is a flow diagrams for the syntheses of oligopeptides (poly amino acids, peptide nucleic acids or other oligopeptides).
- the coupling is carried out with carbodiimide in conjunction with N-hydroxysuccinimide.
- the solid bar connecting the COOH function to the electrode is made of condensed amino acids.
- the amino acids may be natural amino acids or amino acids not found in nature.
- Figure 3 is a flow diagram for the synthesis of oligonucleotides.
- the syntheses is modulated by the electrochemically generated protons.
- the local pH drops and the protecting dimethoxytrityl (DMT) on the 5' end of the ohgonucleotide is cleaved. The cleavage enables the extension of the ohgonucleotide.
- DMT dimethoxytrityl
- Figure 4 is a flow diagram showing the synthesis of an oligopeptide with an electrochemically pH modulated enzyme catalyzed step.
- Figure 5 is a schematic diagram showing the computerized automated potentiostatic and liquid delivery control to the microelectrode array.
- the electronic device of the invention includes an array of selectively addressable microelectrodes.
- a matrix comprising at least carbon (C) and hydrogen (H), and preferably capable of conducting electrons or holes, and also of conducting ions, is disposed on a surface of the electrodes.
- the conductive matrix is disposed on the microelectrode with a thickness greater than 3 nanometers, and preferably in the range of 3 nanometers to 20 microns, most preferably with a thickness of 5 or more nanometers.
- the matrix comprises a redox polymer or redox hydrogel, having a molecular weight of more than 10 4 daltons.
- the redox polymer or hydrogel comprises a fast redox couple, such as complexes of transition metals such as osmium, ruthenium, iron, copper, and cobalt.
- the matrix is modified to include functional reactive groups, such as amines, aldehydes, carboxyllic acids, active esters, and the like.
- the arrays of electrodes on which the combinatorial syntheses is carried out are usually large. Typically the number of electrodes in the array is greater than 4, greater than 100, and is preferably greater 1000 and it is most preferably greater than 10,000.
- the longest dimension of a microelectrode is preferably less than 100 ⁇ m, and is more preferably between 0.1 and 10 ⁇ m.
- the shape of a microelectrode may be, for example, oval, rectangular or preferably circular. Fine line electrodes, that are typically longer than 100 ⁇ m and have typical widths between 0.1 ⁇ m and 20 ⁇ m, can also be used. It is not necessary that the microelectrode surface be flat.
- a metal or carbon microelectrode surface may be, for example, concave or convex relative to the plane of the surrounding insulating layer.
- all the microelectrodes in the array are of the same dimensions and are spaced individually, or grouped in elements of the array, those elements forming organized patterns.
- the pattern have repeating elements and it is particularly preferred that the elements have rotational and/or translational symmetry.
- An example of a preferred pattern is one where all electrodes except those at the periphery of the array are equidistant from each other and have the same number of nearest neighbors.
- the electrodes typically it is desirable to space the electrodes at distances greater than 10 times the diameter or smallest dimension of the microelectrodes and it is most preferred to space the electrodes at distances greater than 20 times the diameter or smallest dimension of the microelectrodes. It is generally desirable to make the electrodes small, so as to minimize the amount of material consumed in the reaction driven at a subset of electrodes. Preferably fewer than one hundred million molecules are reacted at an electrode. It is more preferred that fewer than one million be reacted and it is most preferred that fewer than one hundred thousand be reacted. Reduction of electrode size also allows closer spacing of electrodes in an array, i.e. denser packing, meaning more electrodes per unit area.
- the density of microelectrodes is greater than 100/cm 2 ; and most preferably it is greater than 100,000/cm 2 .
- the electrodes are made of a conductor which is preferably non-corroding and may comprise gold, carbon, tantalum, ruthenium dioxide, a conductive metal carbide, a conductive metal nitride, or a conductive metal oxide, or a Group VIII metal such as platinum, iridium, rhodium, rhenium, palladium or ruthenium.
- the electrodes are insulated from each other by an insulator that may be organic or inorganic. Examples of inorganic insulators are silicon dioxide and silicon nitride and insulating doped silicon.
- organic insulators are polymers, such as poly(methyl methacrylate), polyimides, polyesters, or polyamides.
- the substrate of the structure can be any material having the desired mechanical properties such as glass, ceramic, silicon, plastic, or a metal coated with an insulating film.
- the electrical contacts to each element in the array may be in the plane of the electrodes, or in the plane of the electrodes and in a second plane, or in multiple planes including or excluding the plane of the electrodes. Contacts to the electrodes may be formed individually to each electrode, to groups of electrodes, or to rows and columns of electrodes in a grid.
- the elements of the array i.e. its microelectrodes
- Hard wiring means that the connection involves a continuous electrical path through electrical conductors, particularly metallic conductors or carbon. Connection by light is possible when a photoconductor is used, so that the illuminated areas conduct electrons or holes, while the non-illuminated areas do not conduct.
- the potential at or the current passing through a microelectrode of the array can also be photogenerated.
- the microelectrode material be or comprise a semiconductor.
- the semiconductor may be an inorganic semiconductor, such as silicon or a III-V compound. It may also be an organic compound, such as a polymeric or non- polymeric organic compound used in light emitting diodes or photodiodes or photovoltaic cells.
- the electrochemical circuits require, in addition to the microelectrodes on which the syntheses are carried out, known as working electrodes, at least one reference electrode and may require at least one counter-electrode, that may or may not be the reference electrode. These added electrodes may be part of the array or may not be part of it.
- the reference electrode may be a conventional reference electrode such as a saturated calomel or silver/silver chloride electrode or it may be a pseudo-reference electrode consisting of a conducting material in contact with the solution.
- the counter electrode can be a conducting material with a surface area which is preferably to at least twice the sum of the combined surfaces area of the microelectrodes in the working electrode array. There may only be one reference electrode and one counter electrode for the entire array.
- the electrode surface may be modified with reactive groups in a variety of ways depending in the electrode material of choice. Two examples are shown in Figure 1. On the left, a matrix with remote reactive functions R, such as a carboxylic acid functions, extending into the solution is shown. On the right, a polymeric gel/hydrogel support incorporating reactive functions R, such as carboxylic acid groups, attached to the back bone of the polymer is shown. Preferably the matrix should not be detached under the conditions of the reaction that is to be carried out. If the reaction is carried out under potentiostatic control, it is preferred that the potential which is applied should affect only the reactive groups or their reactions, not their attachment to the electrode.
- the conducting microelectrode, or group of microelectrodes, or the surface of the entire microelectrode array, including the surface of the insulating material between the electrodes, may be modified with a matrix.
- This matrix can, for example, be a matrix having affinity for a reactant, such as a polycation when the reactant is a nucleotide or a nucleotide derivative which is an anion. It can also be a matrix comprising a redox polymer or a redox hydrogel, the polymer or gel containing attached redox centers. When a redox hydrogel or conductive polymer is used, it is preferred that only the conducting region of the array be covered.
- an array of desired chemical compounds is selectively synthesized on selectively addressable microelectrodes.
- a potential sufficient to cause a Faradaic reaction in the immediate vicinity of the microelectrode is selectively applied to each microelectrode to induce binding of a first reactant to one or more funcional reactive groups present in the matrix disposed on the microelectrode.
- the selective application of potential is repeated to cause a second Faradaic reaction and induce binding of a second reactant to the first bound reactant. This procedure is repeated a sufficient number of times to synthesize a desired compound on the microelectrode, thus forming an array of individual compounds.
- the reactants may be, for example, nucleotides, amino acids, chemical moieties, or other molecular subunits such as oligonucleotides or peptides that are induced to bind amines, aldehydes, carboxylic acids, active esters, and the present in the matrix.
- the Faradaic reaction preferably causes a chemcial change in one or more of the factional reactive groups in the matrix, in a reactant supplied to the microelectrode, for example in a solution bathing the electrode, or in a further chemical species present in the solution.
- the chemical change can result in a change in pH, in the oxidation or reduction of a functional reactive group on the matrix, of the supplied reactant, or of a further chemical species in the reaction solution.
- a Faradaic current is a current that passes when a species is electrooxidized or electroreduced at an electrode. This current is contrasted with a capacitive or polarization current where a current will flow for a period of time when a potential is applied without an electrooxidation or electroreduction reaction taking place.
- the capacitive or polarization current flows as a result of the redistribution of ions in the solution (or film) near the electrode.
- the electrophoretic process where a macromolecular polyelectrolyte migrates to an electrode is such a non-Faradaic process. After some time this current stops because of the accumulation of cations near a negative electrode or of anions near a positive electrode.
- a substance Upon flow of a Faradaic current, a substance is electro lyzed. At least one species in the immediate vicinity of the microelectrode (that is, the distance from the microelectrode where the microelectrode can cause redox reactions) is electrooxidized and at least one species is electroreduced. As a result, there is a net change in the chemical composition in the immediate vicinity of the microelectrode, not a mere re-distribution of ions in the cell.
- the threshold potential is the formal half cell potential for the reaction driven. When the reaction is reversible, then the potential is the thermodynamic potential, - ⁇ G/(nF), where ⁇ G is the change in the Gibbs free energy, n is the number of electrons gained or lost by the reduced or oxidized species and F is Faraday's constant.
- the threshold potential for electrolysis of water is 1.23 V (measured relative the standard hydrogen electrode). A Faradaic current resulting in water electrolysis flows only when this potential is exceeded.
- Acid is produced by electrolysis of water at a half cell potential depending on the pH and temperature. The higher the pH, the more reducing (negative) this potential is, shifting at 25°C by 59 mV for each pH unit (when the partial pressure of hydrogen is fixed).
- Reversible potentials are listed in most handbooks of chemistry, such as the Handbook of Chemistry and Physics.
- the Faradaic reaction need not be reversible. For example, when ascorbic acid is electrooxidized the reaction is irreversible.
- the composition of the solution within the cell changes in the reaction. The compound is not only redistributed but converted.
- the local concentration of ions, particularly of protons, and thus the local pH can be controlled through controlling the current density passing through a particular electrode, which can be in turn, controlled by the applied potential.
- protons Upon electrooxidation, protons are usually released and upon electroreduction protons are usually consumed.
- the reactant in the faradaic process can be oxygen, the solvent itself, e.g. water; a readily electrooxidizable organic compound such as ascorbic acid, or a readily electroreducible organic compound, such as benzoquinone.
- the reactant can also be an inorganic or metal-organic ion, such as a complex of iron, cobalt, ruthenium, osmium or copper.
- the reactant can be a bipyridine complex of ruthenium or osmium or cobalt; a cyanide complex of iron; or a metallocene derivative, such as a ferrocene derivative.
- the metal of the electrode or a metal ion may be reduced or oxidized to an oxidation state which is suitable for the modulation of the chemical reaction at the surface of the electrode.
- the reactant may also be an organic molecule which can be electroreduced or electrooxidized to a species which chelates with a dissolved metal ion.
- the electrochemically formed chelator reduces the local free metal ion concentration at the electrode surface.
- the local concentration of ions at a particular microelectrode or group of microelectrodes may be controlled by a capacitive process, such as a process of attracting cations, repelling cations, attracting anions or repelling anions.
- a capacitive process such as a process of attracting cations, repelling cations, attracting anions or repelling anions.
- the anions attracted or repelled are hydrated protons (H + ), hydroxide anions (OH " ) and Zv ' , Mg 2+ , Ca 2+ or Cu 2+ ions.
- the potential applied to the electrode for eletrophoretic transport and concentration of a charged species is mirrored by the ions in the solution.
- a positive applied potential relative to the potential of zero charge (PZC) of the particular metal in the solution
- PZC potential of zero charge
- the attracted anions will replace cations at the surface.
- the pH or ion concentration in the proximity of an electrode can be controlled through the potential applied, and/or the buffer added to the solution and/or the concentration of the relevant ion in the solution.
- the number of electrodes in the array is greater than ten thousand and the dimension of each microelectrode is 10 ⁇ m or smaller.
- the use of microelectrodes ensures that mass transport of species to and away from the electrode surface is efficient. Concentration polarization, which is the change in concentration of a reactant near an operating electrode, and is important in defining the necessary spacing of the electrodes, is also reduced when microelectrodes are used. Thus denser electrode arrays can be made.
- concentration polarization meaning the distance to which a concentration change extends from a particular electrode depends on the diffusion coefficient of the reactant, the dimension of the microelectrode and the applied potential.
- the occurrence or prevention of a reaction at a particular electrode is controlled by applying a potential to, or passing a current through, the electrode at which the occurrence of the reaction is desired or in which the occurrence of the reaction is to be prevented.
- the application of a potential induces a faradaic or non- faradaic process, depending upon the specific potential applied and the species present in the vicinity of the electrode, which changes the concentration of at least one ion or molecule relative to the bulk solution.
- the concentration of an ion near a particular microelectrode can be controlled through a faradaic process, such as an electroreduction reaction or an electrooxidation reaction. It is well known that the potential where an electrooxidation or electroreduction reaction takes place depends on the presence of a particular electrooxidizable or electroreducible species in the solution. In general the local pH at and near the electrode surface is increased when an electroreduction reaction is taking place and is decreased when an electrooxidation reaction is taking place. Usually the higher the current density the greater the change in local pH. The magnitude of the change also depends on the concentration of buffering agents, decreasing when the buffer concentration is raised. For example, the local pH may be increased at a microelectrode by the electroreduction of oxygen, a reaction where protons are consumed.
- the pH can be decreased locally by the electrooxidation of water to hydrogen peroxide or to oxygen, or by the electrooxidation of a solute, such as ascorbate ion, that takes place at a less oxidizing potential than the potential for electrooxidation of water. In these reactions protons are released.
- the extent of pH change may be controlled by the potential applied or by the buffering capacity of the solution. In summary the local concentration of a particular species near a particular electrode is controlled through the potential applied or the current passed, or by the concentration and nature of an added buffer.
- a reactive species such as an O-acylisourea or an N- hydroxysuccinimide ester does not react with an amine in an acid environment, where the amine is protonated. However, at neutral or slightly basic pH the reaction with the amine does take place and an amide is formed.
- Examples of non-faradaic processes whereby the local concentration of an ion is changed include local increase of the concentration of a cation when a negative potential is applied to an electrode; increase in the local concentration of an anion when a positive potential is applied; local decrease in concentration of a cation when a positive potential is applied; and local decrease in the concentration of an anion when a negative potential is applied.
- the above four processes do not require the occurrence of an electrochemical reaction.
- Examples of such reactions include the syntheses of amides such as those of oligopeptides including peptides, proteins and in peptide nucleic acids via a carbodiimide involving reaction; syntheses involving N-hydroxysuccinimide esters; syntheses involving imidates; and synthesis involving polyphosphates.
- Figure 2 shows an example of a flow diagram of a synthesis utilizing a carbodiimide and N-hydroxysuccinimide for the formation of a peptide bond on an electrode surface.
- an epoxide may be used for a reaction with an amine; or an alkyl halide, particularly an alkyl iodide or an alkyl bromide, for a reaction of an amine.
- the reaction takes place in neutral or basic solutions, but not in acid ones.
- Control can be either by adjusting the local pH through a faradaic or a non- faradaic process such that the reaction proceeds, or through inhibiting the reaction through adjusting the local pH such that the reaction is prevented.
- Figure 3 shows the flow diagram of a current or a potential controllable synthetic route, based on the phosphoramidite method and involving a dimethoxytrityl (DMT) protecting group on the 5' terminus of the reacting base.
- DMT dimethoxytrityl
- the iodine required for the oxidation step may be electrochemically generated when the solution comprises iodide ions. Any unreacted ohgonucleotide is capped by acylation with acetic anhydride to avoid extension of any undesired sequences. This capping is not shown in Figure 3.
- the families of enzymes known to catalyze the hydrolysis or formation of amides in peptides, proteins, and protein nucleic acids and of phosphate ester links in oligonucleotides or DNA and of glycosidic linkages in oligosaccharides include, for example, kinases, peptidases, proteolytic enzymes and hydrolases, transferases, ligases.
- the enzymes' activity can be controlled by the local adjustment of the pH.
- the activity of some enzymes may be enhanced by the local electrochemical reaction or process (meaning application of potential or passage of current) increase in the concentration of ions such as Mg" + , Ca 2+ , or Zn 2+ , or may be decreased by electrochemically increasing the local concentration of ions such as Cu 2+ .
- the enzyme may cause the addition, through formation of a covalent bond, of a dissolved species in the solution to which the array is exposed; or it may be such that it cleaves a terminal function on a molecule already on the electrode so as to enable a reaction at that particular electrode; or it may cause hydrolysis of a functional group of a molecule on an electrode.
- FIG. 4 A schematic diagram of the steps involved in the enzyme catalyzed reaction is shown in figure 4.
- the method described is the step by step synthesis of a peptide nucleic acid modulated by a non-specific amidase, particularly acrylamide amidohydrolase from Pseudomonas aeruginosa. Enrichment of the zone near the microelectrode in protons prevents the enzymatic cleavage of the terminal amide and therefore the subsequent carbodiimide or N-hydroxysuccinimide ester (NHS) utilizing condensation reaction whereby an amino acid is added to the peptide, peptide nucleic acid or protein on the electrode.
- NPS N-hydroxysuccinimide ester
- the system may be automated by integrating a computer to control the flow of liquid containing reactants by a series of valves and also the potentiostat as shown in figure 5.
- a series of different oligonucleotides can be formed on an array of electrodes using the apparatus illustrated in figure 5 and the process illustrated in figure 3.
- An array of carbon or metallic electrodes is formed.
- Each of the electrodes is coated with a coupling species.
- the coupling species includes a reactive functionality that is initially capped with a protective group.
- the array is placed within a flow device that is coupled to a valve, which is, in turn, coupled to four reservoirs of molecular subunits, corresponding to the four different bases of DNA; adenine, guanine, thymine, and cytosine.
- Each of the molecular subunits includes a first reactive functionality for coupling to a deprotected reactive functionality of the coupling species or a previously deposited molecular subunit.
- Each of the molecular subunits also includes a second reactive functionality that is initially capped by a protecting group.
- the valve is directed to open and allow one of the four solutions of molecular subunits to flow into contact with the array.
- Each electrode of the array is individually coupled to a potentiostat, typically, under computer-control.
- a potential is selectively applied to (or, alternatively, a current is passed through) those electrodes at which the particular molecular subunit is to be deposited.
- the electrical potential (or current) causes a change in the concentration of an anionic or cationic species (e.g., a change in pH) that leads to the removal of the protecting group on the coupling species and results in a reaction of the reactive subunit on the coupling species and the first reactive functionality of the molecular subunit.
- the solution containing the first molecular subunit is then removed and the valve is directed to open and allow a second solution with a different molecular subunit to flow into contact with the array.
- a potential is selectively applied to those electrodes at which this particular molecular subunit is to be attached, including those electrode at which this second molecular subunit is to be attached to the first molecular subunit.
- the application of the potential results in the removal of the protecting group from the reactive group of the coupling species or the second reactive group of the previously coupled molecular subunit. This procedure is repeated until the desired ohgonucleotide sequences are all formed on the array of electrodes.
- a four electrode array can be formed with the following oligonucleotides on the electrodes: Electrode 1 - AGTC Electrode 2 - ATGC Electrode 3 - GTGC
- Electrode 4 - TGCA One exemplary process includes the steps in the following table:
- a potential is applied to a microelectrode of the array or a current is passed through an electrode of the array, such that the local pH is changed or the local concentration of another ion is changed.
- the reactive material on the microelectrode is a metal or metal oxide
- the application of a positive potential, or the occurrence of a local electrooxidation reaction can accelerate the dissolution of the oxide or the metal.
- metals, such as zinc or aluminum, or an oxide of such metals are more rapidly dissolved by a local rise in pH. The rate of removal is adjusted through local control of the pH, the potential, or the current.
- the amount of residual material residing on an electrode after partial stripping of a layer can be increased or decreased.
- the amount of residual material may be increased when the film is in an etching solution, such as an acid solution.
- the removal and/or deposition of inorganic material can be useful in a variety of circumstances, including, for example, the combinatorial formation of non- stoichiometric materials. These materials are often tested for various properties, including, for example, fluorescence wavelength, fluorescence quantum yield, magnetic properties, and dielectric constant. It is often useful to test a range of different non-stoichiometric combinations. A material is "non-stoichiometric" if the composition can not be expressed as a chemical formula using numbers or integers of smaller than five.
- One method for forming a range of non-stoichiometric combinations includes forming an array of metal electrodes 102 on a substrate 114, as shown in Figure 1. By selectively applying different potentials or by varying the duration of the applied potential to the electrodes of the array, different amounts of the electrode can be removed.
- the rate of removal is determined, at least in part, by the local concentration of other anionic or cationic species around the electrode. This local concentration is modified by the potential applied to the electrode. For example, the pH can be altered by applying a potential, which can then cause the dissolution of the a portion of the metal electrode.
- the amount of the metal electrode that is removed depends, at least in part, on the potential, the current density through the electrode, and the period of time the potential is applied or the current is passed. By varying any of these parameters across the array, the amount of material removed varies.
- a second metal can be deposited on the electrodes and the process of applying a potential is repeated. This can continue for any number of metal deposition steps.
- the metal may be selectively deposited by applying a potential that causes electroreduction of metal cations from a solution. The amount of metal that is deposited depends on the potential, the current density through the electrode, and the period of time the potential is applied.
- porous films of metal compounds such as, for example, metal oxides, can be formed on the electrode and a portion of the metal compounds can be selectively removed by applying a potential.
- the metal and/or metal compounds can be converted into a desired alloy or compound by, for example, heating, oxidation, sulfidation, other chemical reactions, or consolidation of the various layers.
- This method can be useful for the formation of an array of different non- stoichiometric combinations of materials, each combination being determined, at least in part, by the particular potentials and durations applied to the electrode during each step.
- Yet another means of control involves increasing the local concentration of an anion with which the metal of the electrode may react to form a soluble complex.
- gold is known to react at mildly oxidizing potentials with dissolved chloride ions. If the local concentration of chloride ions is increased by applying a positive potential, then the rate of the dissolution of the gold will also increase, even if the local pH is unchanged.
- solution phase inorganic or mixed organic-inorganic compounds such as halides or alkoxides of Si, Ti, Zr or Al
- the nature and reactivity of the product may be controlled at an electrode of the array through the local change in pH.
- the formation of the solution phase inorganic or mixed organic-inorganic compounds, such as a polymer can be controlled by application or non-application of a potential to each electrode in the array.
- the structure of the compound may, at least in some cases, be dependent on the potential applied at the electrode.
- the polymer formed upon hydrolysis of a silicone precursor, such as methyl trimethoxysilane depends on the local pH.
- Ladder-type silsesquioxanes are often formed at higher pH.
- PVP-Os-NH 2 A redox polymer comprising a poly (4-vinyl pyridinie) backbone here about 0.10 of the pyridines are complexed with [Os(bpy) 2 Cl]" /2* ; and about 20% are reacted with 2-bromoethylamine and are thereby quartemized ( bpy is 2,2'-bipyridine; PEGDGE is poly(ethylene glycol)diglycidyl ether , molecular weight 400-600; SCE is standard calomel electrode potential.
- An array of four gold electrodes is produced on a quartz plate, each electrode spaced a distance of 100 micrometers from the other, and insulated from eachother. Each gold electrode (2 micrometers in diameter) is connected to a contact pad.
- a solution of PVP-OS-NH 2 (10 mg/ml) is incubated with PEGDGE (1 mg/ml) for two hours at 37°C, pH7.
- the electrodes are placed into contact with the PVP-OS-NH 2 / PEGDGE solution, and a potential of -0.6 Volts (SCE) is applied for 10 minutes to electrophoretically deposit and crosslink the redox polymer.
- the solution is replaced with a solution of oligonucleotides (DNA or RNA) (10 mg/ml), and the potential is reversed to +0.6 Volts (SCE) for ten minutes.
- the array is then placed into a solution of ascorbic acid and sodium ascorbate (pH 7.5), total concentration 0.5mM.
- a potential of 0.4 volts (SCE) is then applied to two of the electrodes of the array.
- a drop of micrococcal nuclease (300,000 U/ml) from Staphlococcus aureus is added to the array.
- DNA or RNA is hydrolized only at those electrodes to which no potential is applied, and is not hydrolyzed at those electrodes at those electrodes to which a potential is applied.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU48337/99A AU4833799A (en) | 1998-06-24 | 1999-06-24 | Combinatorial electrochemical syntheses |
US09/746,840 US20020008038A1 (en) | 1998-06-24 | 2000-12-22 | Combinatorial Electrochemical Synthesis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9052098P | 1998-06-24 | 1998-06-24 | |
US60/090,520 | 1998-06-24 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/746,840 Continuation US20020008038A1 (en) | 1998-06-24 | 2000-12-22 | Combinatorial Electrochemical Synthesis |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999067019A1 true WO1999067019A1 (en) | 1999-12-29 |
Family
ID=22223147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/014459 WO1999067019A1 (en) | 1998-06-24 | 1999-06-24 | Combinatorial electrochemical syntheses |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020008038A1 (en) |
AU (1) | AU4833799A (en) |
WO (1) | WO1999067019A1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001094666A3 (en) * | 2000-06-08 | 2002-07-18 | Ylektra Inc | Spatially addressable electrolysis platform and methods of use |
US7052591B2 (en) | 2001-09-21 | 2006-05-30 | Therasense, Inc. | Electrodeposition of redox polymers and co-electrodeposition of enzymes by coordinative crosslinking |
WO2006133042A3 (en) * | 2005-06-06 | 2007-02-01 | Intel Corp | Method and apparatus to fabricate polymer arrays on patterned wafers using electrochemical synthesis |
US7267751B2 (en) | 2002-08-20 | 2007-09-11 | Nanogen, Inc. | Programmable multiplexed active biologic array |
US7932213B2 (en) | 1999-05-11 | 2011-04-26 | President And Fellows Of Harvard College | Small molecule printing |
US7955798B2 (en) | 2004-08-25 | 2011-06-07 | Roche Diagnostics Operations, Inc. | Reusable substrate for DNA microarray production |
US8940143B2 (en) | 2007-06-29 | 2015-01-27 | Intel Corporation | Gel-based bio chip for electrochemical synthesis and electrical detection of polymers |
CN105764540A (en) * | 2013-09-29 | 2016-07-13 | 苏黎世大学 | Electrochemically engineered surface of hydrogels, particularly PEG hydrogels, for enhanced cellular penetration |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071384B2 (en) | 1997-12-22 | 2011-12-06 | Roche Diagnostics Operations, Inc. | Control and calibration solutions and methods for their use |
US7390667B2 (en) * | 1997-12-22 | 2008-06-24 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using AC phase angle measurements |
US7407811B2 (en) * | 1997-12-22 | 2008-08-05 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using AC excitation |
US7077721B2 (en) | 2000-02-17 | 2006-07-18 | Applied Materials, Inc. | Pad assembly for electrochemical mechanical processing |
CA2470812A1 (en) * | 2001-12-17 | 2003-06-26 | Michael Strathmann | Combinatorial synthesis on arrays |
US7645421B2 (en) | 2003-06-20 | 2010-01-12 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US7645373B2 (en) * | 2003-06-20 | 2010-01-12 | Roche Diagnostic Operations, Inc. | System and method for coding information on a biosensor test strip |
US8206565B2 (en) | 2003-06-20 | 2012-06-26 | Roche Diagnostics Operation, Inc. | System and method for coding information on a biosensor test strip |
US8058077B2 (en) | 2003-06-20 | 2011-11-15 | Roche Diagnostics Operations, Inc. | Method for coding information on a biosensor test strip |
US7604721B2 (en) | 2003-06-20 | 2009-10-20 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US7718439B2 (en) | 2003-06-20 | 2010-05-18 | Roche Diagnostics Operations, Inc. | System and method for coding information on a biosensor test strip |
US8148164B2 (en) * | 2003-06-20 | 2012-04-03 | Roche Diagnostics Operations, Inc. | System and method for determining the concentration of an analyte in a sample fluid |
US7452457B2 (en) * | 2003-06-20 | 2008-11-18 | Roche Diagnostics Operations, Inc. | System and method for analyte measurement using dose sufficiency electrodes |
US7597793B2 (en) * | 2003-06-20 | 2009-10-06 | Roche Operations Ltd. | System and method for analyte measurement employing maximum dosing time delay |
US7556723B2 (en) * | 2004-06-18 | 2009-07-07 | Roche Diagnostics Operations, Inc. | Electrode design for biosensor |
US7569126B2 (en) | 2004-06-18 | 2009-08-04 | Roche Diagnostics Operations, Inc. | System and method for quality assurance of a biosensor test strip |
US7572356B2 (en) * | 2004-08-31 | 2009-08-11 | Lifescan Scotland Limited | Electrochemical-based sensor with a redox polymer and redox enzyme entrapped by a dialysis membrane |
US20060172881A1 (en) * | 2004-12-22 | 2006-08-03 | Devaraj Neal K | Method of spatially controlling catalysis of a chemical reaction |
WO2007087377A2 (en) * | 2006-01-25 | 2007-08-02 | Massachusetts Institute Of Technology | Photoelectrochemical synthesis of high density combinatorial polymer arrays |
EP3569306B1 (en) * | 2018-05-17 | 2020-11-25 | IMEC vzw | Synthesis device |
US11592420B2 (en) | 2020-07-17 | 2023-02-28 | Robert Bosch Gmbh | Closed-loop PH control with differential sensor |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5605662A (en) * | 1993-11-01 | 1997-02-25 | Nanogen, Inc. | Active programmable electronic devices for molecular biological analysis and diagnostics |
US5667667A (en) * | 1992-04-24 | 1997-09-16 | Isis Innovation Limited | Electrochemical treatment of surfaces |
WO1998001221A1 (en) * | 1996-07-05 | 1998-01-15 | Combimatrix Corporation | Electrochemical solid phase synthesis of polymers |
WO1998014641A1 (en) * | 1996-10-02 | 1998-04-09 | Symyx Technologies | Potential masking systems and methods for combinatorial library synthesis |
-
1999
- 1999-06-24 AU AU48337/99A patent/AU4833799A/en not_active Abandoned
- 1999-06-24 WO PCT/US1999/014459 patent/WO1999067019A1/en active Application Filing
-
2000
- 2000-12-22 US US09/746,840 patent/US20020008038A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5667667A (en) * | 1992-04-24 | 1997-09-16 | Isis Innovation Limited | Electrochemical treatment of surfaces |
US5605662A (en) * | 1993-11-01 | 1997-02-25 | Nanogen, Inc. | Active programmable electronic devices for molecular biological analysis and diagnostics |
WO1998001221A1 (en) * | 1996-07-05 | 1998-01-15 | Combimatrix Corporation | Electrochemical solid phase synthesis of polymers |
WO1998014641A1 (en) * | 1996-10-02 | 1998-04-09 | Symyx Technologies | Potential masking systems and methods for combinatorial library synthesis |
Non-Patent Citations (2)
Title |
---|
THIERRY LIVACHE ET AL.: "Electrodonducting polymers for the construction of DNA or peptide arrays on silicon chips", BIOSENSORS & BIOELECTRONICS., vol. 13, 1998, BARKING, ESSEX., GB, pages 629 - 634, XP002122942 * |
THIERRY LIVACHE ET AL.: "Polypyrrole DNA Chip on a SIlicon Device: Example of Hepatitis C Virus Genotyping", ANALYTICAL BIOCHEMISTRY., vol. 255, 1998, ACADEMIC PRESS INC. NEW YORK., US, pages 188 - 194, XP002114813, ISSN: 0003-2697 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7932213B2 (en) | 1999-05-11 | 2011-04-26 | President And Fellows Of Harvard College | Small molecule printing |
WO2001094666A3 (en) * | 2000-06-08 | 2002-07-18 | Ylektra Inc | Spatially addressable electrolysis platform and methods of use |
US7052591B2 (en) | 2001-09-21 | 2006-05-30 | Therasense, Inc. | Electrodeposition of redox polymers and co-electrodeposition of enzymes by coordinative crosslinking |
US7267751B2 (en) | 2002-08-20 | 2007-09-11 | Nanogen, Inc. | Programmable multiplexed active biologic array |
US7955798B2 (en) | 2004-08-25 | 2011-06-07 | Roche Diagnostics Operations, Inc. | Reusable substrate for DNA microarray production |
US8053774B2 (en) | 2005-06-06 | 2011-11-08 | Intel Corporation | Method and apparatus to fabricate polymer arrays on patterned wafers using electrochemical synthesis |
WO2006133042A3 (en) * | 2005-06-06 | 2007-02-01 | Intel Corp | Method and apparatus to fabricate polymer arrays on patterned wafers using electrochemical synthesis |
US8278121B2 (en) | 2005-06-06 | 2012-10-02 | Intel Corporation | Method and apparatus to fabricate polymer arrays on patterned wafers using electrochemical synthesis |
US9085461B2 (en) | 2005-06-06 | 2015-07-21 | Intel Corporation | Method and apparatus to fabricate polymer arrays on patterned wafers using electrochemical synthesis |
US10035147B2 (en) | 2005-06-06 | 2018-07-31 | Intel Corporation | Wafer with gel-based biochips for electrochemical synthesis and electrical detection of polymers |
US8940143B2 (en) | 2007-06-29 | 2015-01-27 | Intel Corporation | Gel-based bio chip for electrochemical synthesis and electrical detection of polymers |
CN105764540A (en) * | 2013-09-29 | 2016-07-13 | 苏黎世大学 | Electrochemically engineered surface of hydrogels, particularly PEG hydrogels, for enhanced cellular penetration |
CN105764540B (en) * | 2013-09-29 | 2021-07-02 | 苏黎世大学 | Electrochemically engineered surfaces of hydrogels, especially PEG hydrogels, for enhanced cell penetration |
Also Published As
Publication number | Publication date |
---|---|
AU4833799A (en) | 2000-01-10 |
US20020008038A1 (en) | 2002-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20020008038A1 (en) | Combinatorial Electrochemical Synthesis | |
US8278121B2 (en) | Method and apparatus to fabricate polymer arrays on patterned wafers using electrochemical synthesis | |
Anne et al. | Dynamics of Electron Transport by Elastic Bending of Short DNA Duplexes. Experimental Study and Quantitative Modeling of the Cyclic Voltammetric Behavior of 3 ‘-Ferrocenyl DNA End-Grafted on Gold | |
US8647821B2 (en) | Method and apparatus for combined electrochemical synthesis and detection of analytes | |
US5667667A (en) | Electrochemical treatment of surfaces | |
US10035147B2 (en) | Wafer with gel-based biochips for electrochemical synthesis and electrical detection of polymers | |
JP3247957B2 (en) | Conductive polymer / nucleotide copolymer, production method thereof and use thereof | |
US8614086B2 (en) | Quality control methods for the manufacture of polymer arrays | |
US8999724B2 (en) | Method and apparatus for match quality analysis of analyte binding | |
EP0637344B1 (en) | Electrochemical treatment of surfaces | |
JP2009509175A (en) | Method and CMOS-type device for analyzing molecules and nanomaterials by electrically reading selective binding events on functional electrodes | |
JP2002501307A (en) | Gettering device for ion capture | |
US10294526B2 (en) | Polymer co-location in surface-attached biopolymers and arrays of biopolymers | |
US8410027B2 (en) | Density modification in arrays of surface-attached nucleic acid molecules | |
US20020051975A1 (en) | Reporterless genosensors using electrical detection methods | |
Souteyrand et al. | Use of microtechnology for DNA chips implementation | |
US20060008818A1 (en) | Carbon electrode surface for attachment of DNA and protein molecules | |
GARNIER | New Generation of DNA Chips Based on Real-Time Biomimetic Recognition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 09746840 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |